Psychometric evaluation of the Arabic Version the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20)

References

• Beijers, A., Mols, F., Dercksen, W., Driessen, C., & Vreugdenhil, G. (2016). Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy. Journal of Community and Supportive Oncology, 12, 401–406.
   Google Scholar
• Calhoun, E. A., Welshman, E., Chang, C.-H., Lurain, J., Fishman, D., Hunt, T., & Cella, D. (2003). Psychometric evaluation of the functional assessment of cancer therapy/gynecologic oncology group—neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecologic Cancer, 13(6), 741–748. doi:10.1136/ijgc-00009577-200311000-00003
   PubMed Web of Science ®Google Scholar
• Cavaletti, G., & CI-PERINOMS Study Group. (2012). The chemotherapy-induced peripheral neuropathy outcome measures standardization (CI-Perinoms) study: An answer to the unsettled question of drug-related neuropathy assessment in cancer patients. European Association of NeuroOncology Magazine, 2(1), 37–40.
   Google Scholar
• Cavaletti, G., Cornblath, D., Merkies, I., Postma, T., Rossi, E., Frigeni, B., … Argyriou, A. (2012). The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Annals of Oncology, 24(2), 454–462.
   PubMed Web of Science ®Google Scholar
• Cavaletti, G., & Group, C.-P. S. (2012). The Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-Perinoms) Study: An Answer to the Unsettled Question of Drug-Related Neuropathy Assessment in Cancer Patients. European Association of NeuroOncology Magazine, 2(1), 37–40.
   Google Scholar
• Cheng, H. L., & Molassiotis, A. (2019). Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life‐Chemotherapy‐Induced Peripheral Neuropathy Questionnaire (EORTC QLQ‐CIPN20) and the Functional Assessment of Cancer‐Gynecologic Oncology Group‐Neurotoxicity subscale (FACT/GOG‐Ntx). Asia-Pacific Journal of Clinical Oncology, 15(1), 56–62. doi:10.1111/ajco.13000
   PubMed Web of Science ®Google Scholar
• Dunlap, B., & Paice, J. A. (2006). Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement. The Journal of Supportive Oncology, 4, 398–399.
   PubMedGoogle Scholar
• Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). The EORTC QLQ-C30 scoring manual (3rd ed.). Brussels, Belgium: EORTC Quality of Life Group.
   Google Scholar
• Griffith, K. A., Merkies, I. S., Hill, E. E., & Cornblath, D. R. (2010). Measures of chemotherapy‐induced peripheral neuropathy: A systematic review of psychometric properties. Journal of the Peripheral Nervous System, 15(4), 314–325. doi:10.1111/j.1529-8027.2010.00292.x
   PubMed Web of Science ®Google Scholar
• Huijer, H. A., Sagherian, K., & Tamim, H. (2013). Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon. Quality of Life Research, 22(6), 1473–1481. doi:10.1007/s11136-012-0261-0
   PubMed Web of Science ®Google Scholar
• Kim, H. Y., Kang, J. H., Youn, H. J., So, H. S., Song, C. E., Chae, S. Y., … Kim, J. Y. (2014). Reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to assess Chemotherapy-induced peripheral neuropathy. Journal of Korean Academy of Nursing, 44(6), 735–742. doi:10.4040/jkan.2014.44.6.735
   PubMed Web of Science ®Google Scholar
• Kneis, S., Wehrle, A., Müller, J., Maurer, C., Ihorst, G., Gollhofer, A., & Bertz, H. (2019). It’s never too late-balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: Results of a randomized controlled trial. BMC Cancer, 19(1), 414. doi:10.1186/s12885-019-5522-7
   PubMedGoogle Scholar
• MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S. (1999). Sample size in factor analysis. Psychological Methods, 4(1), 84.
   Web of Science ®Google Scholar
• Nunnally, J. C., & Bernstein, I. (1994). Psychometric theory (McGraw-Hill Series in Psychology). New York, NY: McGraw-Hill.
   Google Scholar
• Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., … Lucey, R. (2005). The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer, 41(8), 1135–1139. doi:10.1016/j.ejca.2005.02.012
   PubMed Web of Science ®Google Scholar
• Smith, E. M. L., Banerjee, T., Yang, J. J., Bridges, C. M., Alberti, P., Sloan, J. A., & Loprinzi, C. (2019). Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data. Cancer Nursing, 42(3), 179–189. doi:10.1097/NCC.0000000000000596
   PubMed Web of Science ®Google Scholar
• Staff, N. P., Grisold, A., Grisold, W., & Windebank, A. J. (2017). Chemotherapy‐induced peripheral neuropathy: A current review. Annals of Neurology, 81(6), 772–781. doi:10.1002/ana.24951
   PubMed Web of Science ®Google Scholar
• Varricchio, C. G. (2004). Measurement issues concerning linguistic translations. In F. Frank-Stromborg & S. J. Olsen (Eds.), Instruments for clinical health-care research (pp. 56–64). Sudbury, MA: Jones and Bartlett Publishers.
   Google Scholar